Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer.
Journal
Oncology (Williston Park, N.Y.)
ISSN: 0890-9091
Titre abrégé: Oncology (Williston Park)
Pays: United States
ID NLM: 8712059
Informations de publication
Date de publication:
13 May 2020
13 May 2020
Historique:
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
20
8
2021
Statut:
ppublish
Résumé
Triple-negative breast cancer (TNBC), which accounts for approximately 10% to 15% of breast cancers, remains the most aggressive subtype and is characterized by early disease relapse for a subset of patients. TNBC remains a clinical challenge, given the lack of effective targeted treatments such as endocrine therapy for hormone receptor-positive (HR+) tumors or therapies against HER2.
Substances chimiques
Biomarkers, Tumor
0
Poly(ADP-ribose) Polymerase Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM